News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MediciNova, Inc. to Present at the Fourth World Congress of Emergency Medicine



11/15/2012 7:44:06 AM

SAN DIEGO, Nov. 14, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), announced that Dr. Kazuko Matsuda, Chief Medical Officer, will present the results of the phase 2 clinical trial of MN-221 in acute exacerbation of asthma at the Fourth World Congress of Emergency Medicine being held in Cancun, Mexico November 14 through 17.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES